Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nimustine Hydrochloride for Injection

Approval Number

国药准字H20065314

Company北京双鹭药业股份有限公司

Registration Date

January 28, 2021

Previous Approval Numbers

国药准字H20065314

Drug Information

Generic Name

注射用盐酸尼莫司汀

Brand Name

欣博金

Dosage Form

注射剂(冻干粉针剂)

Strength

25mg(以盐酸尼莫司汀计)

Drug Type

化学药品

Registration Date

January 28, 2021

Company Information

Applicant Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市海淀区西三环北路100号金玉大厦1103-1105室

Manufacturing Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市石景山区八大处高科技园区中园路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy